365
Views
15
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Origin and levels of circulating microparticles in normal pregnancy: A longitudinal observation in healthy women

, , , , , , , & show all
Pages 487-495 | Received 31 Dec 2014, Accepted 14 May 2015, Published online: 12 Jun 2015

References

  • Alijotas-Reig J, Palacio-Garcia C, Llurba E, Vilardell-Tarres M. Cell-derived microparticles and vascular pregnancy complications: a systematic and comprehensive review. Fertil Steril 2013;99:441–9.
  • Dusse LM, Rios DR, Pinheiro MB, Cooper AJ, Lwaleed BA. Pre-eclampsia: relationship between coagulation, fibrinolysis and inflammation. Clin Chim Acta 2011;412:17–21.
  • Barco S, Nijkeuter M, Middeldorp S. Pregnancy and venous thromboembolism. Semin Thromb Hemost 2013;39:549–58.
  • Austgulen R, Lien E, Vince G, Redman C. Increased maternal plasma levels of soluble adhesion molecules (ICAM-1, V-CAM-1, E-selectin) in preeclampsia. Eur J Obstet Gynecol Reprod Biol 1997;71:53–8.
  • Clausen T, Djurovic S, Brosstad F, Berg K, Henriksen T. Altered circulating levels of adhesion molecules at 18 week's gestation among women with eventual preeclampsia: indicators of disturbed placentation in absence of evidence of endothelial dysfunction? Am J Obstet Gynecol 2000; 182:321–5.
  • Redman CW, Sargent IL. Circulating microparticles in normal pregnancy and pre-eclampsia. Placenta 2008;29:S73–7.
  • Barteneva NS, Fasler-Kan E, Bernimoulin M, Stern JN, Ponomarev ED, Duckett L, Vorobjev IA. Circulating microparticles: square the circle. BMC Cell Biol 2013;14:23.
  • Wu ZH, Ji CL, Li H, Qiu GX, Gao CJ, Weng XS. Membrane microparticles and diseases. Eur Rev Med Pharmacol Sci 2013;17:2420–7.
  • Burger D, Schock S, Thompson CS, Montezano AC, Hakim AM, Touyz RM. Microparticles: biomarkers and beyond. Clin Sci (Lond) 2013;124:423–41.
  • Rautou PE, Vion AC, Amabile N, Chironi G, Simon A, Tedgui A, Boulanger CM. Microparticles, vascular function, and atherothrombosis. Circ Res 2011;109:593–606.
  • Tissot JD, Rubin O, Canellini G. Analysis and clinical relevance of microparticles from red blood cells. Curr Opin Hematol 2010;17:571–7.
  • Antoniak S, Boltzen U, Eisenreich A, Stellbaum C, Poller W, Schultheiss HP, Rauch U. Regulation of cardiomyocyte full-length tissue factor expression and microparticle release under inflammatory conditions in vitro. J Thromb Haemostasis 2009;7:871–8.
  • Campello E, Spiezia L, Radu CM, Bulato C, Castelli M, Gavasso S, Simioni P. Endothelial, platelet and tissue factor-bearing microparticles in cancer patients with and without venous thrombembolism. Thromb Res 2011;127:473–7.
  • Pirro M, Schillaci G, Bagaglia F, Menecali C, Paltriccia R, Mannarino MR, Capanni M, Velardi A, Mannarino E. Microparticles derived from endothelial progenitor cells in patients at different cardiovascular risk. Atherosclerosis 2008;197;757–67.
  • Lacroix R, Dubois C, Leroyer AS, Sabatier F, Dignat-George F. Revisited role of microparticles in arterial and venous thrombosis. J Thromb Haemost 2013;11:24–35.
  • Markiewicz M, Richard E, Marks N, Ludwicka-Bradley A. Impact of endothelial microparticles on coagulation, inflammation, and angiogenesis in age-related vascular diseases. J Aging Res 2013; doi: 10.1155/2013/734509.
  • Mause SF, Weber C. Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ Res 2010;107:1047–57.
  • Marques FK, Campos FM, Sousa LP, Teixeira-Carvalho A, Dusse LM, Gomes KB. Association of microparticles and preeclampsia. Mol Biol Rep 2013;40:4553–9.
  • Aharon A, Brenner B. Microparticles and pregnancy complications. Thromb Res 2011;127:S67–71.
  • Lippi G, Franchini M, Montagnana M, Salvagno GL, Poli G, Guidi GC. Quality and reliability of routine coagulation testing: can we trust that sample? Blood Coagul Fibrinolysis 2006;17:513–9.
  • van Beers EJ, Schaap MC, Berckmans RJ, Nieuwland R, Sturk A, van Doormaal FF, Meijers JC, Biemond BJ; CURAMA study group. Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease. Haematologica 2009;94:1513–9.
  • Simioni P, Tormene D, Spiezia L, Tognin G, Rossetto V, Radu C, Prandoni P. Inherited thrombophilia and venous thromboembolism. Semin Thromb Hemost 2006;32: 700–8.
  • Rossetto V, Spiezia L, Franz F, Salmaso L, Pozza LV, Gavasso S, Simioni P. The role of antiphospholipid antibodies toward the protein C/protein S system in venous thromboembolic disease. Am J Hematol 2009;84:594–6.
  • Campello E, Spiezia L, Radu CM, Bon M, Gavasso S, Zerbinati P, Woodhams B, Tormene D, Prandoni P, Simioni P. Circulating microparticles in carriers of factor V Leiden with and without a history of venous thrombosis. Thromb Haemost 2012;108:633–9.
  • Robert S, Poncelet P, Lacroix R, Arnaud L, Giraudo L, Hauchard A, Sampol J, Dignat-George F. Standardization of platelet-derived microparticle counting using calibrated beads and a Cytomics FC500 routine flow cytometer: a first step towards multicentre studies? J Thromb Haemost 2009;7:190–7.
  • van Dreden P, Rousseau A, Fontaine S, Woodhams B, Exner T. Clinical evaluation of a new functional test for detection of plasma procoagulant phospholipids. Blood Coag Fibrinolysis 2009;20:494–502.
  • Campello E, Spiezia L, Radu CM, Gavasso S, Woodhams B, Simioni P. Evaluation of a procoagulant phosholipid functional assay as a routine test for measuring circulating microparticle activity. Blood Coagul Fibrinolysis 2014; 25:534–7.
  • Bretelle F, Sabatier F, Desprez D, Camin L, Grunebaum L, Combes V, D’Ercole C, Dignat-George F. Circulating microparticles: a marker of procoagulant state in normal pregnancy and pregnancy complicated by preeclampsia or intra uterine growth restriction. Thromb Haemost 2003;89:486–92.
  • Alijotas-Reig, Palacio-Garcia C, Farran-Codina I, Zarzoso C, Cabero-Roura L, Vilardell-Tarres M. Circulating cell-derived microparticles in women with pregnancy loss. Am J Reprod Immunol 2001;66:199–208.
  • Lok CA, Van Der Post JA, Sargent IL, Hau CM, Sturk A, Boer K, Nieuwland R. Changes in microparticle numbers and cellular origin during pregnancy and preeclampsia. Hyperten Pregnancy 2008;27:344–60.
  • Chen M, Geng JG. P-selectin mediates adhesion of leukocytes, platelets, and cancer cells in inflammation, thrombosis, and cancer growth and metastasis. Arch Immunol Ther Exp 2006;54:75–84.
  • Khew-Goodall Y, Butcher CM, Litwin MS, Newlands S, Korpelainen EI, Noack LM, Berndt MC, Lopez AF, Gamble JR, Vadas MA. Chronic expression of P-selectin on endothelial cells stimulated by the T-cell cytokine, interleukin-3. Blood 1996;87:1432–8.
  • Morel O, Luca F, Grunebaum L. Short-term very low- calorie diet in obese females improves the haemostatic balance through the reduction of leptin levels, PAI-1 concentrations and a diminished release of platelet and leukocyte-derived microparticles. Int J Obes 2011;35:1479–86.
  • Furie B, Furie BC. Mechanisms of thrombus formation. N Engl J Med 2008;359:938–49.
  • Lacroix R, Judicone C, Poncelet P, Robert S, Arnaud L, Sampol J, Dignat-George F. Impact of pre-analytical parameters on the measurement of circulating microparticles: towards standardization of protocol. J Thromb Haemost 2012;10:437–46.
  • Yuana Y, Bertina RM, Osanto S. Pre-analytical and analytical issues in the analysis of blood microparticles. Thromb Haemost 2011;105:396–408.
  • Lacroix R, Judicone C, Mooberry M, Boucekine M, Key NS, Dignat-George F; The ISTH SSC Workshop. Standardization of pre-analytical variables in plasma microparticle determination: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop. J Thromb Haemost 2013;11:1190–3.
  • Robert S, Lacroix R, Poncelet P, Harhouri K, Bouriche T, Judicone C, Wischhusen J, Arnaud L, Dignat-George F. High-sensitivity flow cytometry provides access to standardized measurement of small-size microparticles – brief report. Arterioscler Thromb Vasc Biol 2012;32:1054–8.
  • Lacroix R, Dubois C, Leroyer AS, Sabatier F, Dignat-George F. Revisited role of microparticles in arterial and venous thrombosis. J Thromb Haemost 2013;11:24–35.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.